In vivo engineering of CAR-T cells: delivery strategies and clinical translation

Key Points

• CAR-T cells demonstrate potential to effectively target and combat cancer cells, enhancing treatment options.
• Delivery strategies, including various methods, significantly impact the performance and functionality of CAR-T cells in vivo.
• Clinical translation efforts focus on adapting these advanced CAR-T cell therapies for real-world cancer treatment environments.
• Optimizing delivery methods may enable broader accessibility and effectiveness of CAR-T therapies, impacting patient care.